这是一篇来自已证抗体库的有关小鼠 Hsp90aa1的综述,是根据224篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Hsp90aa1 抗体。
Hsp90aa1 同义词: 86kDa; 89kDa; AL024080; AL024147; Hsp86-1; Hsp89; Hsp90; Hspca; hsp4

圣克鲁斯生物技术
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 1:1000; 图 s1c
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s1c). Nat Commun (2021) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 图 5b
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在小鼠样本上 (图 5b). Aging (Albany NY) (2021) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 1:1000; 图 4a
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4a). iScience (2021) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 1:500; 图 7j
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 7j). Pflugers Arch (2021) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 大肠杆菌; 图 e3c
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, F-8)被用于被用于免疫印迹在大肠杆菌样本上 (图 e3c). Nature (2020) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 图 4a
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, SC?\13119)被用于被用于免疫印迹在小鼠样本上 (图 4a). Oral Dis (2020) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 6c
圣克鲁斯生物技术 Hsp90aa1抗体(Santa, sc-13119)被用于被用于免疫印迹在人类样本上 (图 6c). Cell (2019) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 1:500; 图 4c
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4c). PLoS Biol (2019) ncbi
小鼠 单克隆(F-8)
  • 免疫细胞化学; 人类; 1:100; 图 1d
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 1d). J Cell Biol (2019) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 1:1000; 图 1b
圣克鲁斯生物技术 Hsp90aa1抗体(Santa, sc-13119)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1b). elife (2019) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 2b
圣克鲁斯生物技术 Hsp90aa1抗体(Santa, Sc-515081)被用于被用于免疫印迹在人类样本上 (图 2b). DNA Repair (Amst) (2019) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 1:1000; 图 3a
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3a). Nucleic Acids Res (2018) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 图 1c
  • 核糖核酸免疫沉淀; 人类; 图 s9d
圣克鲁斯生物技术 Hsp90aa1抗体(SantaCruz, F-8)被用于被用于免疫印迹在小鼠样本上 (图 1c) 和 被用于核糖核酸免疫沉淀在人类样本上 (图 s9d). Nature (2017) ncbi
小鼠 单克隆
  • 核糖核酸免疫沉淀; 人类; 图 s9d
  • 免疫印迹; 小鼠; 图 1c
圣克鲁斯生物技术 Hsp90aa1抗体(SantaCruz, F-8)被用于被用于核糖核酸免疫沉淀在人类样本上 (图 s9d) 和 被用于免疫印迹在小鼠样本上 (图 1c). Nature (2017) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 1f
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上 (图 1f). BMC Cancer (2017) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 4d
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上 (图 4d). PLoS ONE (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 3b
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, F-8)被用于被用于免疫印迹在人类样本上 (图 3b). Leuk Res (2017) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 3b
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, F-8)被用于被用于免疫印迹在人类样本上 (图 3b). Leuk Res (2017) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 1h
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上 (图 1h). elife (2016) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 1:1000
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Biol Open (2017) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 图 2
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, 13119)被用于被用于免疫印迹在小鼠样本上 (图 2). J Biol Chem (2016) ncbi
小鼠 单克隆(F-8)
  • 免疫沉淀; 小鼠; 图 2c
  • 免疫组化; 小鼠; 1:50; 图 3
  • 免疫印迹; 小鼠; 1:1000; 图 2c
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫沉淀在小鼠样本上 (图 2c), 被用于免疫组化在小鼠样本上浓度为1:50 (图 3) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2c). J Cell Sci (2016) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 图 3d
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在小鼠样本上 (图 3d). Nat Commun (2016) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上 (图 6). PLoS ONE (2016) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 图 2
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, SC-13119)被用于被用于免疫印迹在小鼠样本上 (图 2). Sci Rep (2016) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 1:2000; 图 s1c
圣克鲁斯生物技术 Hsp90aa1抗体(SantaCruz, sc-13119)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 s1c). Nat Cell Biol (2016) ncbi
小鼠 单克隆(AC88)
  • 免疫印迹; 小鼠; 图 1
圣克鲁斯生物技术 Hsp90aa1抗体(santa Cruz, sc-59577)被用于被用于免疫印迹在小鼠样本上 (图 1). Sci Rep (2016) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 1:1000; 图 6
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6). Nat Commun (2016) ncbi
小鼠 单克隆(AC88)
  • 免疫印迹; 人类; 图 7
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-59577)被用于被用于免疫印迹在人类样本上 (图 7). Oncogene (2016) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnologies, 13119)被用于被用于免疫印迹在人类样本上浓度为1:1000. Oncoscience (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在人类样本上 (图 3). Cell Death Dis (2015) ncbi
小鼠 单克隆(AC88)
  • 流式细胞仪; 人类; 图 1e
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-59577)被用于被用于流式细胞仪在人类样本上 (图 1e). Oncotarget (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 Hsp90aa1抗体(santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上 (图 6). PLoS ONE (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上. Genes Cancer (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 1:1000; 图 5
圣克鲁斯生物技术 Hsp90aa1抗体(santa Cruz, sc-13119)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5). PLoS ONE (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 4a
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在人类样本上 (图 4a). Target Oncol (2015) ncbi
小鼠 单克隆(S88)
  • 免疫印迹; 小鼠; 图 1
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-59578)被用于被用于免疫印迹在小鼠样本上 (图 1). J Virol (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 1:2000
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在小鼠样本上浓度为1:2000. Free Radic Biol Med (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上 (图 5). Int J Biol Sci (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在人类样本上. Transl Res (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上. Cell Signal (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫沉淀; 人类; 图 4
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫沉淀在人类样本上 (图 4). Nucleic Acids Res (2015) ncbi
小鼠 单克隆(AC88)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-59577)被用于被用于免疫印迹在人类样本上 (图 3). Nucleic Acids Res (2014) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在人类样本上. Cell Stress Chaperones (2015) ncbi
小鼠 单克隆(S88)
  • 免疫印迹; 大鼠
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-59578)被用于被用于免疫印迹在大鼠样本上. J Neurosci (2014) ncbi
小鼠 单克隆(F-8)
  • 免疫组化-石蜡切片; 人类; 1:200
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 和 被用于免疫印迹在人类样本上浓度为1:1000. Anticancer Res (2014) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠; 图 5
圣克鲁斯生物技术 Hsp90aa1抗体(Santa, sc-13119)被用于被用于免疫印迹在小鼠样本上 (图 5). Mol Biol Cell (2014) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 1c
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上 (图 1c). Nature (2014) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在小鼠样本上. Biochim Biophys Acta (2014) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在人类样本上. Oncogene (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 5c
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在人类样本上 (图 5c). Oncogene (2015) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, sc-13119)被用于被用于免疫印迹在人类样本上 (图 3). Mol Cancer Ther (2014) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 大鼠
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在大鼠样本上. Am J Physiol Cell Physiol (2014) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz Biotechnology, F-8)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi
小鼠 单克隆(F-8)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Hsp90aa1抗体(Santa Cruz, sc-13119)被用于被用于免疫印迹在人类样本上浓度为1:1000. J Biol Chem (2013) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(D7A)
  • 免疫印迹; 小鼠; 1:500; 图 1f
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab59459)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 1f). Nat Commun (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1f, 2a, b, 5c
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab2928)被用于被用于免疫印迹在人类样本上 (图 1f, 2a, b, 5c). Nat Commun (2020) ncbi
小鼠 单克隆(AC88)
  • 免疫印迹; 小鼠; 图 5c
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(abcam, ab13492)被用于被用于免疫印迹在小鼠样本上 (图 5c). Cancer Discov (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 2a
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab2928)被用于被用于免疫印迹在小鼠样本上 (图 2a). Immunity (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2b
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abacm, ab2928)被用于被用于免疫印迹在人类样本上 (图 2b). Cancer Sci (2018) ncbi
小鼠 单克隆(AC88)
  • 免疫组化; 小鼠; 1:100; 图 s6h
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab13492)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 s6h). Cell (2017) ncbi
domestic rabbit 单克隆(EPR3953)
  • 免疫印迹; 小鼠; 1:2000; 图 2a
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab109248)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 2a). J Exp Med (2017) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 7b
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, 13495)被用于被用于免疫细胞化学在人类样本上 (图 7b). Oncotarget (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 1:500; 图 3b
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, Ab 2928)被用于被用于免疫组化在人类样本上浓度为1:500 (图 3b) 和 被用于免疫印迹在人类样本上. Nature (2016) ncbi
小鼠 单克隆(AC88)
  • 流式细胞仪; 人类; 1:50; 图 3
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(ABCAM, ab13492)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 3). Methods Mol Biol (2016) ncbi
小鼠 单克隆(AC88)
  • 免疫印迹; 人类; 1:1000; 图 3c
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab13492)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 6
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, 13495)被用于被用于免疫细胞化学在人类样本上 (图 6). Front Oncol (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 2b
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab13495)被用于被用于免疫细胞化学在人类样本上 (图 2b). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 2b
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab2928)被用于被用于免疫细胞化学在人类样本上 (图 2b). Oncotarget (2016) ncbi
小鼠 单克隆(D7A)
  • 免疫细胞化学; 人类; 图 5c
  • 免疫印迹; 人类; 图 5a
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab59459)被用于被用于免疫细胞化学在人类样本上 (图 5c) 和 被用于免疫印迹在人类样本上 (图 5a). FASEB J (2016) ncbi
小鼠 单克隆(AC88)
  • 免疫沉淀; 人类; 图 2a
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab13492)被用于被用于免疫沉淀在人类样本上 (图 2a). FASEB J (2016) ncbi
小鼠 单克隆(2G5.G3)
  • 免疫印迹; 大鼠; 1:1000; 图 1
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab79849)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 1). Int J Mol Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 小鼠; 1:100
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab13495)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100. Cell Mol Immunol (2017) ncbi
小鼠 单克隆(AC88)
  • 免疫印迹; 人类; 1:100; 图 3b
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab13492)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 3b). Mol Med Rep (2015) ncbi
小鼠 单克隆(AC88)
  • 免疫印迹; 小鼠
艾博抗(上海)贸易有限公司 Hsp90aa1抗体(Abcam, ab13492)被用于被用于免疫印迹在小鼠样本上. Proteomics (2014) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫沉淀; 人类; 图 2e
  • 免疫组化; 人类; 图 3c
  • 免疫印迹; 人类; 图 2a, 2e
赛默飞世尔 Hsp90aa1抗体(Thermo Fisher Scientific, PA3-013)被用于被用于免疫沉淀在人类样本上 (图 2e), 被用于免疫组化在人类样本上 (图 3c) 和 被用于免疫印迹在人类样本上 (图 2a, 2e). Nat Commun (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; African green monkey; 图 4c
赛默飞世尔 Hsp90aa1抗体(Thermo Pierce, PA3-013)被用于被用于免疫印迹在African green monkey样本上 (图 4c). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s3
赛默飞世尔 Hsp90aa1抗体(Thermo Scientific, PA3-013)被用于被用于免疫印迹在人类样本上 (图 s3). Nucleic Acids Res (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 7
赛默飞世尔 Hsp90aa1抗体(Thermo Scientific, PA3-013)被用于被用于免疫印迹在人类样本上 (图 7). J Med Chem (2016) ncbi
domestic rabbit 多克隆
赛默飞世尔 Hsp90aa1抗体(Affinity BioReagents, PA3-013)被用于. J Biol Chem (2015) ncbi
domestic rabbit 多克隆
赛默飞世尔 Hsp90aa1抗体(Thermo, PA3-013)被用于. Nat Med (2015) ncbi
Novus Biologicals
小鼠 单克隆(AC88)
  • 流式细胞仪; 小鼠; 图 4b
Novus Biologicals Hsp90aa1抗体(Novus, AC88)被用于被用于流式细胞仪在小鼠样本上 (图 4b). Adv Sci (Weinh) (2020) ncbi
BioLegend
小鼠 单克隆(3H3C27)
  • 免疫印迹; 小鼠; 1:1000; 图 1a
BioLegend Hsp90aa1抗体(Biolegend, 675402)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1a). Nat Commun (2019) ncbi
StressMarq Biosciences
小鼠 单克隆(3320)
  • 免疫印迹; 人类; 1:1000; 图 8c
StressMarq Biosciences Hsp90aa1抗体(StressMarq Biosciences, SMC-149)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8c). Eneuro (2019) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 1:1000; 图 4a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling Technology, 4877T)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4a). Cells (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 6b
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling Technology, 4874)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6b). NPJ Aging Mech Dis (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2f, 2g
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(CST, 4874)被用于被用于免疫印迹在人类样本上 (图 2f, 2g). Cell Death Discov (2021) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 3s1-2
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877S)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 3s1-2). elife (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(CST, 4874)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). World J Surg Oncol (2021) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling Technology, 4877)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Nat Commun (2020) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在人类样本上 (图 3a). Cell Death Differ (2020) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 1:1000; 图 4b
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling Technology, 4877S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4b). J Clin Invest (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 s3k
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(CST, 4874)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s3k). J Exp Med (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:10,000; 图 s4f
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(CST, 4874S)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 s4f). Stem Cell Reports (2020) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 1:1000; 图 8a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 8a). elife (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 1f
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling Technology, 4874)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1f). elife (2019) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 s16b
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 s16b). Science (2019) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 3e
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877S)被用于被用于免疫印迹在人类样本上 (图 3e). Cell (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1 ug/ml; 图 s9a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling Technology, 4874)被用于被用于免疫印迹在小鼠样本上浓度为1 ug/ml (图 s9a). Science (2019) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 1:5000; 图 s8e
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signalling, 4877)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 s8e). Science (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4c
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4875)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4c). J Exp Med (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 s6d, s5b
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4874S)被用于被用于免疫印迹在小鼠样本上 (图 s6d, s5b). Cell (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:2000; 图 6a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4874S)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 6a). PLoS ONE (2019) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 1:1000; 图 s4h
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s4h). Immunity (2018) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 图 5b
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877S)被用于被用于免疫印迹在小鼠样本上 (图 5b). Science (2018) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 1:1000; 图 s1d
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s1d). Nat Commun (2018) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 1:1000; 图 s1d
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s1d). J Neuroinflammation (2018) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 1:1000; 图 1a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell signaling, 4877)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1a). Nat Med (2018) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 1:1000; 图 2a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2a). Nat Commun (2018) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 8d
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, C45G5)被用于被用于免疫印迹在人类样本上 (图 8d). J Leukoc Biol (2018) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 5f
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在人类样本上 (图 5f). Cell (2018) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 图 1b
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在小鼠样本上 (图 1b). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 3a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4874S)被用于被用于免疫印迹在小鼠样本上 (图 3a). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4875)被用于被用于免疫印迹在人类样本上 (图 2a). Int J Radiat Biol (2017) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 1:1000; 图 s7a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell signaling, 4877)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s7a). Nat Commun (2017) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 1:1000; 图 4a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4a). Cell (2017) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 1:1000; 图 s5
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s5). J Cell Biol (2017) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 图 s2f
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell signaling, 4877)被用于被用于免疫印迹在小鼠样本上 (图 s2f). Nature (2017) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 2c
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling Technology, 4877)被用于被用于免疫印迹在人类样本上 (图 2c). elife (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6d
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, E289)被用于被用于免疫印迹在人类样本上 (图 6d). Oncotarget (2017) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 1:500; 图 3-s1d
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877S)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 3-s1d). elife (2017) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 图 1c
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, C45G5)被用于被用于免疫印迹在小鼠样本上 (图 1c). elife (2017) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 6a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在人类样本上 (图 6a). Cell (2016) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 小鼠; 图 1b
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在小鼠样本上 (图 1b). Genes Dev (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 3488)被用于被用于免疫印迹在人类样本上 (图 4c). Sci Rep (2016) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 s2
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在人类样本上 (图 s2). Neuroendocrinology (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4874)被用于被用于免疫印迹在人类样本上 (图 1). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Signaling Technology, 4874)被用于被用于免疫印迹在人类样本上 (图 4). J Cell Mol Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; fruit fly ; 1:1000
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4874)被用于被用于免疫印迹在fruit fly 样本上浓度为1:1000. PLoS ONE (2016) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877S)被用于被用于免疫印迹在人类样本上 (图 5). Sci Rep (2016) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 1a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在人类样本上 (图 1a). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signalling, 4874)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). Nat Cell Biol (2016) ncbi
domestic rabbit 多克隆
  • 流式细胞仪; 人类; 1:25; 图 1b
  • 免疫组化; 人类; 图 1a
  • 免疫印迹; 人类; 1:500; 图 1d
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell signaling, 4874)被用于被用于流式细胞仪在人类样本上浓度为1:25 (图 1b), 被用于免疫组化在人类样本上 (图 1a) 和 被用于免疫印迹在人类样本上浓度为1:500 (图 1d). Chem Biol Interact (2016) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫组化-石蜡切片; 人类; 1:4000; 图 st1
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell signaling, 4877S)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:4000 (图 st1) 和 被用于免疫印迹在人类样本上 (图 4). Nature (2016) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; pigs ; 1:1000; 图 1
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling Technology, 4877)被用于被用于免疫印迹在pigs 样本上浓度为1:1000 (图 1). Am J Physiol Regul Integr Comp Physiol (2016) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877S)被用于被用于免疫印迹在人类样本上浓度为1:1000. Nat Cell Biol (2016) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 1:1000; 图 7
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7). elife (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 2b
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, E289)被用于被用于免疫细胞化学在人类样本上 (图 2b). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 7b
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(CST, 3488)被用于被用于免疫印迹在人类样本上 (图 7b). J Biol Chem (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 1c
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4874S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1c). J Biol Chem (2016) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 s1b
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在人类样本上 (图 s1b). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 s4
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, 4877)被用于被用于免疫印迹在人类样本上 (图 s4). Oncogene (2016) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell signaling, C45G5)被用于被用于免疫印迹在人类样本上 (图 5). Cancer Med (2015) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling Technologies, 4877)被用于被用于免疫印迹在人类样本上 (图 5). PLoS ONE (2014) ncbi
domestic rabbit 单克隆(C45G5)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Hsp90aa1抗体(Cell Signaling, C45G5)被用于被用于免疫印迹在人类样本上. J Biol Chem (2013) ncbi
碧迪BD
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:200
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在人类样本上浓度为1:200. Sci Rep (2021) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫细胞化学; 人类; 1:100; 图 2d
碧迪BD Hsp90aa1抗体(BD Biosciences, 611000)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 2d). elife (2021) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:5000; 图 3f
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 3f). Genome Biol (2021) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 1:10,000; 图 2g
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610418)被用于被用于免疫印迹在小鼠样本上浓度为1:10,000 (图 2g). elife (2020) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 1:5000; 图 1c
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 1c). PLoS Genet (2020) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:1000; 图 3b
碧迪BD Hsp90aa1抗体(BD Biosciences, 68)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3b). elife (2020) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫细胞化学; 人类; 图 2g
碧迪BD Hsp90aa1抗体(BD Bioscience, 611000)被用于被用于免疫细胞化学在人类样本上 (图 2g). Nucleic Acids Res (2020) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:4000; 图 6c
碧迪BD Hsp90aa1抗体(BD-Biosciences, 610419)被用于被用于免疫印迹在人类样本上浓度为1:4000 (图 6c). Cell Death Dis (2020) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫组化-冰冻切片; 人类; 图 1e
碧迪BD Hsp90aa1抗体(BD Biosciences, 611000)被用于被用于免疫组化-冰冻切片在人类样本上 (图 1e). Science (2020) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:1000; 图 2d
碧迪BD Hsp90aa1抗体(BD Biosciences, 610419)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2d). Nat Commun (2019) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 3d
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610419)被用于被用于免疫印迹在人类样本上 (图 3d). Mol Cell (2019) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫细胞化学; 人类; 1:100; 图 5a
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 611000)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 5a). elife (2019) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 1d
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在人类样本上 (图 1d). Cell (2019) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 1f
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在人类样本上 (图 1f). Curr Biol (2019) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫印迹; 人类; 图 3b
碧迪BD Hsp90aa1抗体(BD Biosciences, 611000)被用于被用于免疫印迹在人类样本上 (图 3b). Cell (2019) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 s11c
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在人类样本上 (图 s11c). Science (2018) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:2500; 图 2j
碧迪BD Hsp90aa1抗体(BD Biosciences, 610419)被用于被用于免疫印迹在人类样本上浓度为1:2500 (图 2j). Nat Commun (2018) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫细胞化学; 人类; 1:500; 图 1c
碧迪BD Hsp90aa1抗体(BD, 611000)被用于被用于免疫细胞化学在人类样本上浓度为1:500 (图 1c). J Cell Sci (2018) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:4000; 图 3b
碧迪BD Hsp90aa1抗体(BD Biosciences, 610419)被用于被用于免疫印迹在人类样本上浓度为1:4000 (图 3b). Nat Commun (2018) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫细胞化学; 人类; 1:1000; 图 s3a
碧迪BD Hsp90aa1抗体(BD Biosciences, 611000)被用于被用于免疫细胞化学在人类样本上浓度为1:1000 (图 s3a). Nat Commun (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 图 s5h
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610419)被用于被用于免疫印迹在小鼠样本上 (图 s5h). Nat Methods (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 大鼠; 图 1d
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610418)被用于被用于免疫印迹在大鼠样本上 (图 1d). Sci Rep (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 1:5000; 图 1b
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 1b). Biochemistry (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类
碧迪BD Hsp90aa1抗体(BD Biosciences, 610419)被用于被用于免疫印迹在人类样本上. Mol Cell Biol (2017) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫细胞化学; 小鼠; 1:500; 图 5h
  • 免疫印迹; 小鼠; 1:1000; 图 5g
碧迪BD Hsp90aa1抗体(BD, 611000)被用于被用于免疫细胞化学在小鼠样本上浓度为1:500 (图 5h) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5g). J Clin Invest (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:1000; 图 6b
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6b). BMC Pulm Med (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 图 1c
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在小鼠样本上 (图 1c). J Clin Invest (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 图 6b
碧迪BD Hsp90aa1抗体(BD, 610419)被用于被用于免疫印迹在小鼠样本上 (图 6b). Mol Cell Biol (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 1b
碧迪BD Hsp90aa1抗体(BD Bioscience, 610418)被用于被用于免疫印迹在人类样本上 (图 1b). Oncogene (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 s6c
碧迪BD Hsp90aa1抗体(BD Transduction Lab, 610419)被用于被用于免疫印迹在人类样本上 (图 s6c). Nature (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 大鼠; 1:2000; 图 7c
碧迪BD Hsp90aa1抗体(BD Transduction, 610418)被用于被用于免疫印迹在大鼠样本上浓度为1:2000 (图 7c). J Cell Physiol (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:5000; 图 s2a
碧迪BD Hsp90aa1抗体(BD Biosciences, 610419)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 s2a). Nat Commun (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 犬; 1:500; 图 3
碧迪BD Hsp90aa1抗体(BD Biosciences, 610419)被用于被用于免疫印迹在犬样本上浓度为1:500 (图 3). Int J Hyperthermia (2017) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 图 2k
碧迪BD Hsp90aa1抗体(BD Transduction, 610419)被用于被用于免疫印迹在小鼠样本上 (图 2k). Cell Cycle (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 图 3
碧迪BD Hsp90aa1抗体(BD Transduction Labs, 610419)被用于被用于免疫印迹在小鼠样本上 (图 3). PLoS Genet (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 大鼠; 图 3a
  • 免疫印迹; 小鼠; 图 9h
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610418)被用于被用于免疫印迹在大鼠样本上 (图 3a) 和 被用于免疫印迹在小鼠样本上 (图 9h). Sci Rep (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 1:1000; 图 7f
碧迪BD Hsp90aa1抗体(BD Biosciences, 610419)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7f). Nat Commun (2016) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫细胞化学; 人类; 图 3
  • 免疫印迹; 人类; 图 3
碧迪BD Hsp90aa1抗体(BD Bioscience, 611000)被用于被用于免疫细胞化学在人类样本上 (图 3) 和 被用于免疫印迹在人类样本上 (图 3). Protein Cell (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 4h
碧迪BD Hsp90aa1抗体(BD, 68/Hsp90)被用于被用于免疫印迹在人类样本上 (图 4h). Science (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 2
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610419)被用于被用于免疫印迹在人类样本上 (图 2). Mol Cell Biol (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 5e
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610418)被用于被用于免疫印迹在人类样本上 (图 5e). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 3
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610419)被用于被用于免疫印迹在人类样本上 (图 3). IUBMB Life (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 其他; 人类; 图 st1
碧迪BD Hsp90aa1抗体(BD, 68)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 图 4
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在小鼠样本上 (图 4). Cancer Discov (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 图 1
碧迪BD Hsp90aa1抗体(BD Biosciences, 68/Hsp90)被用于被用于免疫印迹在小鼠样本上 (图 1). J Immunol (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 1:1000; 图 3
碧迪BD Hsp90aa1抗体(BD Transduction Labs, 68)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). Nat Commun (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 2
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在人类样本上 (图 2). Am J Physiol Lung Cell Mol Physiol (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:5000; 图 3a
碧迪BD Hsp90aa1抗体(BD, 610418)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 3a). Mol Brain (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 2
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在人类样本上 (图 2). Cell Mol Life Sci (2016) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 1:500; 图 4f
碧迪BD Hsp90aa1抗体(BD, 610419)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4f). PLoS ONE (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 1
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610418)被用于被用于免疫印迹在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 图 2
碧迪BD Hsp90aa1抗体(BD Transduction laboratories, 610419)被用于被用于免疫印迹在小鼠样本上 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 图 5
碧迪BD Hsp90aa1抗体(BD Transduction Laboratorie, 610419)被用于被用于免疫印迹在小鼠样本上 (图 5). Genes Dev (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 鸡; 1:1000
碧迪BD Hsp90aa1抗体(BD Bioscience, 610418)被用于被用于免疫印迹在鸡样本上浓度为1:1000. Biosci Biotechnol Biochem (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 s6
碧迪BD Hsp90aa1抗体(BD, 610418)被用于被用于免疫印迹在人类样本上 (图 s6). Nature (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类
碧迪BD Hsp90aa1抗体(BD Transduction Labs, 610418)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 图 4
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在小鼠样本上 (图 4). PLoS Pathog (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 1:1000; 图 7
碧迪BD Hsp90aa1抗体(BD Transduction laboratories, 610418)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7). Eur J Pharmacol (2015) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 1:1000
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610419)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. PLoS ONE (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类
碧迪BD Hsp90aa1抗体(BD Transduction, 610419)被用于被用于免疫印迹在人类样本上. Cell Death Dis (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610418)被用于被用于免疫印迹在人类样本上. Proteomics (2015) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫组化; 小鼠; 1:400
碧迪BD Hsp90aa1抗体(BD Biosciences, 611000)被用于被用于免疫组化在小鼠样本上浓度为1:400. Mol Cell Biol (2014) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫细胞化学; 小鼠
碧迪BD Hsp90aa1抗体(BD Transduction lab, 611000)被用于被用于免疫细胞化学在小鼠样本上. PLoS Genet (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:3000; 图 2
碧迪BD Hsp90aa1抗体(BD, 610419)被用于被用于免疫印迹在人类样本上浓度为1:3000 (图 2). Nat Cell Biol (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610418)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610418)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类
碧迪BD Hsp90aa1抗体(BD Biosciences, 610419)被用于被用于免疫印迹在人类样本上. Mol Cell Biol (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 7f
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在人类样本上 (图 7f). PLoS ONE (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类
碧迪BD Hsp90aa1抗体(BD Biosciences, 610418)被用于被用于免疫印迹在人类样本上. Antimicrob Agents Chemother (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类
碧迪BD Hsp90aa1抗体(BD, 610419)被用于被用于免疫印迹在人类样本上. Mol Cell Biol (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类
碧迪BD Hsp90aa1抗体(BD Biosciences, 610419)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 1:1000
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610418)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. PLoS ONE (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 大鼠; 1:1000
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610418)被用于被用于免疫印迹在大鼠样本上浓度为1:1000. Lab Invest (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:3000
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610419)被用于被用于免疫印迹在人类样本上浓度为1:3000. PLoS Genet (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:2000; 图 1a
碧迪BD Hsp90aa1抗体(BD Transduction lab, 610419)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 1a). Nat Cell Biol (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 大鼠; 图 s3
碧迪BD Hsp90aa1抗体(BD Transduction, 610418)被用于被用于免疫印迹在大鼠样本上 (图 s3). Nat Neurosci (2014) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠
碧迪BD Hsp90aa1抗体(BD Transduction laboratories, 610418)被用于被用于免疫印迹在小鼠样本上. Physiol Rep (2013) ncbi
小鼠 单克隆(27/LAP2)
  • 免疫组化-石蜡切片; 小鼠; 1:400
碧迪BD Hsp90aa1抗体(BD, 611000)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:400. Proc Natl Acad Sci U S A (2013) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 1:3000
碧迪BD Hsp90aa1抗体(BD Biosciences, 610419)被用于被用于免疫印迹在小鼠样本上浓度为1:3000. FASEB J (2013) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 1:1000; 图 7
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610419)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7). Mol Pharmacol (2013) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 小鼠; 图 4
碧迪BD Hsp90aa1抗体(BD Transduction, 610419)被用于被用于免疫印迹在小鼠样本上 (图 4). Proc Natl Acad Sci U S A (2012) ncbi
小鼠 单克隆(68/Hsp90)
  • 免疫印迹; 人类; 图 5
碧迪BD Hsp90aa1抗体(BD Transduction Laboratories, 610418)被用于被用于免疫印迹在人类样本上 (图 5). Nat Immunol (2011) ncbi
西格玛奥德里奇
小鼠 单克隆(AC-16)
  • 免疫印迹; 大鼠; 1:1000; 图 8
西格玛奥德里奇 Hsp90aa1抗体(Sigma, H1775)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 8). PLoS ONE (2016) ncbi
小鼠 单克隆(AC-16)
  • 免疫印迹; 大鼠; 图 6
西格玛奥德里奇 Hsp90aa1抗体(Sigma-Aldrich, H1775)被用于被用于免疫印迹在大鼠样本上 (图 6). J Biophotonics (2015) ncbi
文章列表
  1. Lee Y, Gil E, Jeong I, Kim H, Jang J, Choung Y. Heat Shock Factor 1 Prevents Age-Related Hearing Loss by Decreasing Endoplasmic Reticulum Stress. Cells. 2021;10: pubmed 出版商
  2. Banerjee S, Ghoshal S, Girardet C, Demars K, Yang C, Niehoff M, et al. Adropin correlates with aging-related neuropathology in humans and improves cognitive function in aging mice. NPJ Aging Mech Dis. 2021;7:23 pubmed 出版商
  3. Zhang Y, Ma Y, Wu G, Xie M, Luo C, Huang X, et al. SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression. Cell Death Discov. 2021;7:192 pubmed 出版商
  4. Prekovic S, Schuurman K, Mayayo Peralta I, Manjón A, Buijs M, Yavuz S, et al. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Nat Commun. 2021;12:4360 pubmed 出版商
  5. Shani O, Raz Y, Monteran L, Scharff Y, Levi Galibov O, Megides O, et al. Evolution of fibroblasts in the lung metastatic microenvironment is driven by stage-specific transcriptional plasticity. elife. 2021;10: pubmed 出版商
  6. Baik S, Selvaraji S, Fann D, Poh L, Jo D, Herr D, et al. Hippocampal transcriptome profiling reveals common disease pathways in chronic hypoperfusion and aging. Aging (Albany NY). 2021;13:14651-14674 pubmed 出版商
  7. Shin S, Zhou H, He C, Wei Y, Wang Y, Shingu T, et al. Qki activates Srebp2-mediated cholesterol biosynthesis for maintenance of eye lens transparency. Nat Commun. 2021;12:3005 pubmed 出版商
  8. Li W, Zheng J, Zhao G, Lyu C, Lu W. Overexpression of DSCR1 prevents proliferation and predicts favorable prognosis in colorectal cancer patients. World J Surg Oncol. 2021;19:100 pubmed 出版商
  9. Rippe C, Morén B, Liu L, Stenkula K, Mustaniemi J, Wennström M, et al. NG2/CSPG4, CD146/MCAM and VAP1/AOC3 are regulated by myocardin-related transcription factors in smooth muscle cells. Sci Rep. 2021;11:5955 pubmed 出版商
  10. Chen X, Yao H, Kashif M, Revêchon G, Eriksson M, Hu J, et al. A small-molecule ICMT inhibitor delays senescence of Hutchinson-Gilford progeria syndrome cells. elife. 2021;10: pubmed 出版商
  11. Li L, Ugalde A, Scheele C, Dieter S, Nagel R, Ma J, et al. A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis. Genome Biol. 2021;22:54 pubmed 出版商
  12. Singh S, Abu Zaid A, Lin W, Low J, Abdolvahabi A, Jin H, et al. 17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcoma. iScience. 2021;24:101996 pubmed 出版商
  13. Schilpp C, Lochbaum R, Braubach P, Jonigk D, Frick M, Dietl P, et al. TGF-β1 increases permeability of ciliated airway epithelia via redistribution of claudin 3 from tight junction into cell nuclei. Pflugers Arch. 2021;473:287-311 pubmed 出版商
  14. Ow J, Cadez M, Zafer G, Foo J, Li H, Ghosh S, et al. Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division. elife. 2020;9: pubmed 出版商
  15. Dewhurst M, Ow J, Zafer G, Van Hul N, Wollmann H, Bisteau X, et al. Loss of hepatocyte cell division leads to liver inflammation and fibrosis. PLoS Genet. 2020;16:e1009084 pubmed 出版商
  16. Wang H, Radomska H, Phelps M, Iorns E, Tsui R, Denis A, et al. Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. elife. 2020;9: pubmed 出版商
  17. Silva M, Nandi G, Tentarelli S, Gurrell I, Jamier T, Lucente D, et al. Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons. Nat Commun. 2020;11:3258 pubmed 出版商
  18. Bekeschus S, Clemen R, Nießner F, Sagwal S, Freund E, Schmidt A. Medical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion. Adv Sci (Weinh). 2020;7:1903438 pubmed 出版商
  19. Hu H, Ji Q, Song M, Ren J, Liu Z, Wang Z, et al. ZKSCAN3 counteracts cellular senescence by stabilizing heterochromatin. Nucleic Acids Res. 2020;48:6001-6018 pubmed 出版商
  20. Wu Y, Chou T, Young L, Hsieh F, Pan H, Mo S, et al. Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation. Cell Death Dis. 2020;11:305 pubmed 出版商
  21. Simula L, Corrado M, Accordi B, Di Rita A, Nazio F, Antonucci Y, et al. JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction. Cell Death Differ. 2020;: pubmed 出版商
  22. Alajati A, D Ambrosio M, Troiani M, Mosole S, Pellegrini L, Chen J, et al. CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. J Clin Invest. 2020;130:2435-2450 pubmed 出版商
  23. Hermanova I, Z iga Garc a P, Caro Maldonado A, Fernandez Ruiz S, Salvador F, Mart n Mart n N, et al. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer. J Exp Med. 2020;217: pubmed 出版商
  24. Topalian S, Taube J, Pardoll D. Neoadjuvant checkpoint blockade for cancer immunotherapy. Science. 2020;367: pubmed 出版商
  25. Song K, Oh S, Kim S, Cho H, Lee H, Song J, et al. HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors. Nat Commun. 2020;11:562 pubmed 出版商
  26. Inda M, Joshi S, Wang T, Bolaender A, Gandu S, Koren Iii J, et al. The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction. Nat Commun. 2020;11:319 pubmed 出版商
  27. Li Y, Haarhuis J, Cacciatore Á, Oldenkamp R, van Ruiten M, Willems L, et al. The structural basis for cohesin-CTCF-anchored loops. Nature. 2020;: pubmed 出版商
  28. Ahfeldt T, Ordureau A, Bell C, Sarrafha L, Sun C, Piccinotti S, et al. Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons. Stem Cell Reports. 2020;14:75-90 pubmed 出版商
  29. Choi S, Shin S, Lee H, Sohn K, Yoon S, Kim J. 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol ameliorates chemoradiation-induced oral mucositis. Oral Dis. 2020;26:111-121 pubmed 出版商
  30. Klotz R, Thomas A, Teng T, Han S, Iriondo O, Li L, et al. Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers. Cancer Discov. 2020;10:86-103 pubmed 出版商
  31. Lopez V, Park B, Nowak D, Sreelatha A, Zembek P, Fernandez J, et al. A Bacterial Effector Mimics a Host HSP90 Client to Undermine Immunity. Cell. 2019;179:205-218.e21 pubmed 出版商
  32. Matsumoto S, Yamamichi T, Shinzawa K, Kasahara Y, Nojima S, Kodama T, et al. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling. Nat Commun. 2019;10:3882 pubmed 出版商
  33. Stavoe A, Gopal P, Gubas A, Tooze S, Holzbaur E. Expression of WIPI2B counteracts age-related decline in autophagosome biogenesis in neurons. elife. 2019;8: pubmed 出版商
  34. Sharma A, Oonthonpan L, Sheldon R, Rauckhorst A, Zhu Z, Tompkins S, et al. Impaired skeletal muscle mitochondrial pyruvate uptake rewires glucose metabolism to drive whole-body leanness. elife. 2019;8: pubmed 出版商
  35. Yang Y, Xie J, Wang D, Kim J, Tai P, Gravallese E, et al. Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis. Nat Commun. 2019;10:2958 pubmed 出版商
  36. Gkatza N, Castro C, Harvey R, Heiß M, Popis M, Blanco S, et al. Cytosine-5 RNA methylation links protein synthesis to cell metabolism. PLoS Biol. 2019;17:e3000297 pubmed 出版商
  37. Chaves Pérez A, Yilmaz M, Perna C, de la Rosa S, Djouder N. URI is required to maintain intestinal architecture during ionizing radiation. Science. 2019;364: pubmed 出版商
  38. Halfmann C, Sears R, Katiyar A, Busselman B, Aman L, Zhang Q, et al. Repair of nuclear ruptures requires barrier-to-autointegration factor. J Cell Biol. 2019;: pubmed 出版商
  39. Stefanius K, Servage K, de Souza Santos M, Gray H, Toombs J, Chimalapati S, et al. Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation. elife. 2019;8: pubmed 出版商
  40. Chino H, Hatta T, Natsume T, Mizushima N. Intrinsically Disordered Protein TEX264 Mediates ER-phagy. Mol Cell. 2019;74:909-921.e6 pubmed 出版商
  41. Blair L, Criado Marrero M, Zheng D, Wang X, Kamath S, Nordhues B, et al. The Disease-Associated Chaperone FKBP51 Impairs Cognitive Function by Accelerating AMPA Receptor Recycling. Eneuro. 2019;6: pubmed 出版商
  42. Jeppesen D, Fenix A, Franklin J, Higginbotham J, Zhang Q, Zimmerman L, et al. Reassessment of Exosome Composition. Cell. 2019;177:428-445.e18 pubmed 出版商
  43. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed 出版商
  44. Lieb S, Blaha Ostermann S, Kamper E, Rippka J, Schwarz C, Ehrenhöfer Wölfer K, et al. Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells. elife. 2019;8: pubmed 出版商
  45. Castel P, Cheng A, Cuevas Navarro A, Everman D, Papageorge A, Simanshu D, et al. RIT1 oncoproteins escape LZTR1-mediated proteolysis. Science. 2019;363:1226-1230 pubmed 出版商
  46. Gong B, Kiyotani K, Sakata S, Nagano S, Kumehara S, Baba S, et al. Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer. J Exp Med. 2019;: pubmed 出版商
  47. Ganeshan K, Nikkanen J, Man K, Leong Y, Sogawa Y, Maschek J, et al. Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance. Cell. 2019;: pubmed 出版商
  48. Liu W, Wang G, Palovcak A, Li Y, Hao S, Liu Z, et al. Impeding the single-strand annealing pathway of DNA double-strand break repair by withaferin A-mediated FANCA degradation. DNA Repair (Amst). 2019;77:10-17 pubmed 出版商
  49. Liu R, Jagannathan R, Li F, Lee J, Balasubramanyam N, Kim B, et al. Tead1 is required for perinatal cardiomyocyte proliferation. PLoS ONE. 2019;14:e0212017 pubmed 出版商
  50. Lin C, Zhang Y, Zhang K, Zheng Y, Lu L, Chang H, et al. Fever Promotes T Lymphocyte Trafficking via a Thermal Sensory Pathway Involving Heat Shock Protein 90 and α4 Integrins. Immunity. 2019;50:137-151.e6 pubmed 出版商
  51. Jachimowicz R, Beleggia F, Isensee J, Velpula B, Goergens J, Bustos M, et al. UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors. Cell. 2019;176:505-519.e22 pubmed 出版商
  52. Rausch V, Bostrom J, Park J, Bravo I, Feng Y, Hay D, et al. The Hippo Pathway Regulates Caveolae Expression and Mediates Flow Response via Caveolae. Curr Biol. 2019;29:242-255.e6 pubmed 出版商
  53. Mirza A, McKellar S, Urman N, Brown A, Hollmig T, Aasi S, et al. LAP2 Proteins Chaperone GLI1 Movement between the Lamina and Chromatin to Regulate Transcription. Cell. 2019;176:198-212.e15 pubmed 出版商
  54. Bigenzahn J, Collu G, Kartnig F, Pieraks M, Vladimer G, Heinz L, et al. LZTR1 is a regulator of RAS ubiquitination and signaling. Science. 2018;362:1171-1177 pubmed 出版商
  55. Mollaoglu G, Jones A, Wait S, Mukhopadhyay A, Jeong S, Arya R, et al. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment. Immunity. 2018;49:764-779.e9 pubmed 出版商
  56. Albrengues J, Shields M, Ng D, Park C, Ambrico A, Poindexter M, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361: pubmed 出版商
  57. Kim H, Mun Y, Lee K, Park Y, Park J, Park J, et al. T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells. Nat Commun. 2018;9:3630 pubmed 出版商
  58. Morris K, Corbett A. The polyadenosine RNA-binding protein ZC3H14 interacts with the THO complex and coordinately regulates the processing of neuronal transcripts. Nucleic Acids Res. 2018;46:6561-6575 pubmed 出版商
  59. Yao F, Zhou Z, Kim J, Hang Q, Xiao Z, Ton B, et al. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity. Nat Commun. 2018;9:2269 pubmed 出版商
  60. Huang W, Lin S, Chen H, Chen Y, Chen T, Hsu K, et al. NADPH oxidases as potential pharmacological targets against increased seizure susceptibility after systemic inflammation. J Neuroinflammation. 2018;15:140 pubmed 出版商
  61. Zhang Z, Zi Z, Lee E, Zhao J, Contreras D, South A, et al. Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis. Nat Med. 2018;24:617-627 pubmed 出版商
  62. Platani M, Samejima I, Samejima K, Kanemaki M, Earnshaw W. Seh1 targets GATOR2 and Nup153 to mitotic chromosomes. J Cell Sci. 2018;131: pubmed 出版商
  63. Mo Z, Zhao X, Liu H, Hu Q, Chen X, Pham J, et al. Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy. Nat Commun. 2018;9:1007 pubmed 出版商
  64. Taylor J, Cash M, Santostefano K, Nakanishi M, Terada N, Wallet M. CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophages. J Leukoc Biol. 2018;: pubmed 出版商
  65. Hsieh W, Hsu T, Chang Y, Lai M. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells. Nat Commun. 2018;9:463 pubmed 出版商
  66. Janes M, Zhang J, Li L, Hansen R, Peters U, Guo X, et al. Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor. Cell. 2018;172:578-589.e17 pubmed 出版商
  67. Moriya C, Taniguchi H, Nagatoishi S, Igarashi H, Tsumoto K, Imai K. PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78. Cancer Sci. 2018;109:373-383 pubmed 出版商
  68. Jiang Y, Lin X, Tang Z, Lee C, Tian G, Du Y, et al. Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK. Proc Natl Acad Sci U S A. 2017;114:10737-10742 pubmed 出版商
  69. Zhao T, Hong Y, Yin P, Li S, Li X. Differential HspBP1 expression accounts for the greater vulnerability of neurons than astrocytes to misfolded proteins. Proc Natl Acad Sci U S A. 2017;114:E7803-E7811 pubmed 出版商
  70. Takaki T, Montagner M, Serres M, Le Berre M, Russell M, Collinson L, et al. Actomyosin drives cancer cell nuclear dysmorphia and threatens genome stability. Nat Commun. 2017;8:16013 pubmed 出版商
  71. Azimzadeh O, Subramanian V, Ständer S, Merl Pham J, Lowe D, Barjaktarovic Z, et al. Proteome analysis of irradiated endothelial cells reveals persistent alteration in protein degradation and the RhoGDI and NO signalling pathways. Int J Radiat Biol. 2017;93:920-928 pubmed 出版商
  72. Olivares O, Mayers J, Gouirand V, Torrence M, Gicquel T, Borge L, et al. Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat Commun. 2017;8:16031 pubmed 出版商
  73. Tan S, Chadha S, Liu Y, Gabasova E, Perera D, Ahmed K, et al. A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability. Cell. 2017;169:1105-1118.e15 pubmed 出版商
  74. Ganguly A, Han X, Das U, Wang L, Loi J, Sun J, et al. Hsc70 chaperone activity is required for the cytosolic slow axonal transport of synapsin. J Cell Biol. 2017;216:2059-2074 pubmed 出版商
  75. Rogers Z, McFarland C, Winters I, Naranjo S, Chuang C, Petrov D, et al. A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nat Methods. 2017;14:737-742 pubmed 出版商
  76. Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 2017;545:500-504 pubmed 出版商
  77. Lim J, Ibaseta A, Fischer M, Cancilla B, O Young G, Cristea S, et al. Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. Nature. 2017;545:360-364 pubmed 出版商
  78. Rippe C, Zhu B, Krawczyk K, Bavel E, Albinsson S, Sjölund J, et al. Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway. Sci Rep. 2017;7:1334 pubmed 出版商
  79. Melville Z, Hernández Ochoa E, Pratt S, Liu Y, Pierce A, Wilder P, et al. The Activation of Protein Kinase A by the Calcium-Binding Protein S100A1 Is Independent of Cyclic AMP. Biochemistry. 2017;56:2328-2337 pubmed 出版商
  80. Zhang X, Spiegelman N, Nelson O, Jing H, Lin H. SIRT6 regulates Ras-related protein R-Ras2 by lysine defatty-acylation. elife. 2017;6: pubmed 出版商
  81. de la Mare J, Jurgens T, Edkins A. Extracellular Hsp90 and TGFβ regulate adhesion, migration and anchorage independent growth in a paired colon cancer cell line model. BMC Cancer. 2017;17:202 pubmed 出版商
  82. Shizu R, Osabe M, Perera L, Moore R, Sueyoshi T, Negishi M. Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation. Mol Cell Biol. 2017;37: pubmed 出版商
  83. Voráčová K, Hajek J, Mares J, Urajová P, Kuzma M, Cheel J, et al. The cyanobacterial metabolite nocuolin a is a natural oxadiazine that triggers apoptosis in human cancer cells. PLoS ONE. 2017;12:e0172850 pubmed 出版商
  84. Li H, Liu P, Xu S, Li Y, Dekker J, Li B, et al. FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging. J Clin Invest. 2017;127:1241-1253 pubmed 出版商
  85. Booth L, Roberts J, Sander C, Lee J, Kirkwood J, Poklepovic A, et al. The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo. Oncotarget. 2017;8:16367-16386 pubmed 出版商
  86. Stefanowicz D, Ullah J, Lee K, Shaheen F, Olumese E, Fishbane N, et al. Epigenetic modifying enzyme expression in asthmatic airway epithelial cells and fibroblasts. BMC Pulm Med. 2017;17:24 pubmed 出版商
  87. Hattori A, McSkimming D, Kannan N, Ito T. RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia. Leuk Res. 2017;54:47-54 pubmed 出版商
  88. Walker L, Summers D, Sasaki Y, Brace E, Milbrandt J, DiAntonio A. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2. elife. 2017;6: pubmed 出版商
  89. Stein S, Lemos V, Xu P, Demagny H, Wang X, Ryu D, et al. Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease. J Clin Invest. 2017;127:583-592 pubmed 出版商
  90. Nagaraj R, Sharpley M, Chi F, Braas D, Zhou Y, Kim R, et al. Nuclear Localization of Mitochondrial TCA Cycle Enzymes as a Critical Step in Mammalian Zygotic Genome Activation. Cell. 2017;168:210-223.e11 pubmed 出版商
  91. Yamauchi T, Nishiyama M, Moroishi T, Kawamura A, Nakayama K. FBXL5 Inactivation in Mouse Brain Induces Aberrant Proliferation of Neural Stem Progenitor Cells. Mol Cell Biol. 2017;37: pubmed 出版商
  92. Zhao B, Hu W, Kumar S, Gonyo P, Rana U, Liu Z, et al. The Nogo-B receptor promotes Ras plasma membrane localization and activation. Oncogene. 2017;36:3406-3416 pubmed 出版商
  93. Araujo L, Khim P, Mkhikian H, Mortales C, Demetriou M. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. elife. 2017;6: pubmed 出版商
  94. Sha L, Wang X, Li J, Shi X, Wu L, Shen Y, et al. Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy. J Exp Med. 2017;214:547-563 pubmed 出版商
  95. Matsumoto A, Pasut A, Matsumoto M, Yamashita R, Fung J, Monteleone E, et al. mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature. 2017;541:228-232 pubmed 出版商
  96. Grossi M, Bhattachariya A, Nordström I, Turczynska K, Svensson D, Albinsson S, et al. Pyk2 inhibition promotes contractile differentiation in arterial smooth muscle. J Cell Physiol. 2017;232:3088-3102 pubmed 出版商
  97. Wu L, Zhou B, Oshiro Rapley N, Li M, Paulo J, Webster C, et al. An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer. Cell. 2016;167:1705-1718.e13 pubmed 出版商
  98. Wada S, Neinast M, Jang C, Ibrahim Y, Lee G, Babu A, et al. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue. Genes Dev. 2016;30:2551-2564 pubmed
  99. Huang Z, Zhou X, He Y, Ke X, Wen Y, Zou F, et al. Hyperthermia enhances 17-DMAG efficacy in hepatocellular carcinoma cells with aggravated DNA damage and impaired G2/M transition. Sci Rep. 2016;6:38072 pubmed 出版商
  100. Shibata E, Kiran M, Shibata Y, Singh S, Kiran S, Dutta A. Two subunits of human ORC are dispensable for DNA replication and proliferation. elife. 2016;5: pubmed 出版商
  101. Booth L, Roberts J, Poklepovic A, Gordon S, Dent P. PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide. Oncotarget. 2017;8:1449-1468 pubmed 出版商
  102. Chavan R, Preitner N, Okabe T, Strittmatter L, Xu C, Ripperger J, et al. REV-ERB? regulates Fgf21 expression in the liver via hepatic nuclear factor 6. Biol Open. 2017;6:1-7 pubmed 出版商
  103. Reuther C, Heinzle V, Nölting S, Herterich S, Hahner S, Halilovic E, et al. The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. Neuroendocrinology. 2018;106:1-19 pubmed 出版商
  104. Chaudhury A, Cheema S, Fachini J, Kongchan N, Lu G, Simon L, et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT. Nat Commun. 2016;7:13362 pubmed 出版商
  105. Keshri G, Gupta A, Yadav A, Sharma S, Singh S. Photobiomodulation with Pulsed and Continuous Wave Near-Infrared Laser (810 nm, Al-Ga-As) Augments Dermal Wound Healing in Immunosuppressed Rats. PLoS ONE. 2016;11:e0166705 pubmed 出版商
  106. Graner A, Hellwinkel J, Lencioni A, Madsen H, Harland T, Marchando P, et al. HSP90 inhibitors in the context of heat shock and the unfolded protein response: effects on a primary canine pulmonary adenocarcinoma cell line. Int J Hyperthermia. 2017;33:303-317 pubmed 出版商
  107. Hinds T, Burns K, Hosick P, McBeth L, Nestor Kalinoski A, Drummond H, et al. Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3? Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) ?. J Biol Chem. 2016;291:25179-25191 pubmed
  108. Rodina A, Wang T, Yan P, Gomes E, Dunphy M, Pillarsetty N, et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. 2016;538:397-401 pubmed 出版商
  109. Okabe T, Chavan R, Fonseca Costa S, Brenna A, Ripperger J, Albrecht U. REV-ERB? influences the stability and nuclear localization of the glucocorticoid receptor. J Cell Sci. 2016;129:4143-4154 pubmed
  110. Myasnikov A, Kundhavai Natchiar S, Nebout M, Hazemann I, Imbert V, Khatter H, et al. Structure-function insights reveal the human ribosome as a cancer target for antibiotics. Nat Commun. 2016;7:12856 pubmed 出版商
  111. Dias M, Martins V, Hajj G. Stress-Inducible Protein 1 (STI1): Extracellular Vesicle Analysis and Quantification. Methods Mol Biol. 2016;1459:161-74 pubmed 出版商
  112. Depaolo J, Wang Z, Guo J, Zhang G, Qian C, Zhang H, et al. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis. Oncotarget. 2016;7:71417-71428 pubmed 出版商
  113. Jayapal S, Ang H, Wang C, Bisteau X, Caldez M, Xuan G, et al. Cyclin A2 regulates erythrocyte morphology and numbers. Cell Cycle. 2016;15:3070-3081 pubmed
  114. Diril M, Bisteau X, Kitagawa M, Caldez M, Wee S, Gunaratne J, et al. Loss of the Greatwall Kinase Weakens the Spindle Assembly Checkpoint. PLoS Genet. 2016;12:e1006310 pubmed 出版商
  115. Krawczyk K, Ekman M, Rippe C, Grossi M, Nilsson B, Albinsson S, et al. Assessing the contribution of thrombospondin-4 induction and ATF6? activation to endoplasmic reticulum expansion and phenotypic modulation in bladder outlet obstruction. Sci Rep. 2016;6:32449 pubmed 出版商
  116. Zhou Q, Yu X, Demirkaya E, Deuitch N, Stone D, Tsai W, et al. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc Natl Acad Sci U S A. 2016;113:10127-32 pubmed 出版商
  117. Ah Koon L, Lesage D, Lemadre E, Souissi I, Fagard R, Varin Blank N, et al. Cellular response to alkylating agent MNNG is impaired in STAT1-deficients cells. J Cell Mol Med. 2016;20:1956-65 pubmed 出版商
  118. Aryal B, Rotllan N, Araldi E, Ramírez C, He S, Chousterman B, et al. ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression. Nat Commun. 2016;7:12313 pubmed 出版商
  119. Williams A, Mehler V, Mueller C, Vonhoff F, White R, Duch C. Apoptotic Activity of MeCP2 Is Enhanced by C-Terminal Truncating Mutations. PLoS ONE. 2016;11:e0159632 pubmed 出版商
  120. Pinet S, Bessette B, Vedrenne N, Lacroix A, Richard L, Jauberteau M, et al. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells. Oncotarget. 2016;7:50349-50364 pubmed 出版商
  121. Tavallai M, Booth L, Roberts J, Poklepovic A, Dent P. Rationally Repurposing Ruxolitinib (Jakafi (®)) as a Solid Tumor Therapeutic. Front Oncol. 2016;6:142 pubmed 出版商
  122. Kim H, Choi M, Inn K, Kim B. Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner. Sci Rep. 2016;6:28896 pubmed 出版商
  123. Sasai K, Katayama H, Hawke D, Sen S. Aurora-C Interactions with Survivin and INCENP Reveal Shared and Distinct Features Compared with Aurora-B Chromosome Passenger Protein Complex. PLoS ONE. 2016;11:e0157305 pubmed 出版商
  124. Bennesch M, Segala G, Wider D, Picard D. LSD1 engages a corepressor complex for the activation of the estrogen receptor ? by estrogen and cAMP. Nucleic Acids Res. 2016;44:8655-8670 pubmed
  125. Shriver M, Marimuthu S, Paul C, Geist J, Seale T, Konstantopoulos K, et al. Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit. Oncotarget. 2016;7:45414-45428 pubmed 出版商
  126. Ahmad F, Chung Y, Tang Y, Hockman S, Liu S, Khan Y, et al. Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue. Sci Rep. 2016;6:28056 pubmed 出版商
  127. Lee J, Takahama S, Zhang G, Tomarev S, Ye Y. Unconventional secretion of misfolded proteins promotes adaptation to proteasome dysfunction in mammalian cells. Nat Cell Biol. 2016;18:765-76 pubmed 出版商
  128. Li Y, Zhang W, Chang L, Han Y, Sun L, Gong X, et al. Vitamin C alleviates aging defects in a stem cell model for Werner syndrome. Protein Cell. 2016;7:478-88 pubmed 出版商
  129. Torrano V, Valcarcel Jimenez L, Cortazar A, Liu X, Urosevic J, Castillo Martin M, et al. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis. Nat Cell Biol. 2016;18:645-656 pubmed 出版商
  130. Pourcet B, Gage M, León T, Waddington K, Pello O, Steffensen K, et al. The nuclear receptor LXR modulates interleukin-18 levels in macrophages through multiple mechanisms. Sci Rep. 2016;6:25481 pubmed 出版商
  131. Galloway A, Saveliev A, Łukasiak S, Hodson D, Bolland D, Balmanno K, et al. RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence. Science. 2016;352:453-9 pubmed 出版商
  132. Okumura F, Uematsu K, Byrne S, Hirano M, Joo Okumura A, Nishikimi A, et al. Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor ?. Mol Cell Biol. 2016;36:1803-17 pubmed 出版商
  133. Venkatesan N, Kanwar J, Deepa P, Navaneethakrishnan S, Joseph C, Krishnakumar S. Targeting HSP90/Survivin using a cell permeable structure based peptido-mimetic shepherdin in retinoblastoma. Chem Biol Interact. 2016;252:141-9 pubmed 出版商
  134. Kaur A, Webster M, Marchbank K, Behera R, Ndoye A, Kugel C, et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature. 2016;532:250-4 pubmed 出版商
  135. Ganesan S, Reynolds C, Hollinger K, Pearce S, Gabler N, Baumgard L, et al. Twelve hours of heat stress induces inflammatory signaling in porcine skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2016;310:R1288-96 pubmed 出版商
  136. Liu X, Xiao Z, Han L, Zhang J, Lee S, Wang W, et al. LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat Cell Biol. 2016;18:431-42 pubmed 出版商
  137. Bigenzahn J, Fauster A, Rebsamen M, Kandasamy R, Scorzoni S, Vladimer G, et al. An Inducible Retroviral Expression System for Tandem Affinity Purification Mass-Spectrometry-Based Proteomics Identifies Mixed Lineage Kinase Domain-like Protein (MLKL) as an Heat Shock Protein 90 (HSP90) Client. Mol Cell Proteomics. 2016;15:1139-50 pubmed
  138. Cannavo A, Liccardo D, Eguchi A, Elliott K, Traynham C, Ibetti J, et al. Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases. Nat Commun. 2016;7:10877 pubmed 出版商
  139. Scheckel C, Drapeau E, Frias M, Park C, Fak J, Zucker Scharff I, et al. Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain. elife. 2016;5: pubmed 出版商
  140. Booth L, Shuch B, Albers T, Roberts J, Tavallai M, Proniuk S, et al. Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function. Oncotarget. 2016;7:12975-96 pubmed 出版商
  141. Ghosh S, Shinogle H, Galeva N, Dobrowsky R, Blagg B. Endoplasmic Reticulum-resident Heat Shock Protein 90 (HSP90) Isoform Glucose-regulated Protein 94 (GRP94) Regulates Cell Polarity and Cancer Cell Migration by Affecting Intracellular Transport. J Biol Chem. 2016;291:8309-23 pubmed 出版商
  142. Bober J, Olsnes S, Kostas M, Bogacz M, Zakrzewska M, Otlewski J. Identification of new FGF1 binding partners-Implications for its intracellular function. IUBMB Life. 2016;68:242-51 pubmed 出版商
  143. Gray L, Rauckhorst A, Taylor E. A Method for Multiplexed Measurement of Mitochondrial Pyruvate Carrier Activity. J Biol Chem. 2016;291:7409-17 pubmed 出版商
  144. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  145. Hall J, Seedarala S, Zhao H, Garg G, Ghosh S, Blagg B. Novobiocin Analogues That Inhibit the MAPK Pathway. J Med Chem. 2016;59:925-33 pubmed 出版商
  146. Roundhill E, Turnbull D, Burchill S. Localization of MRP-1 to the outer mitochondrial membrane by the chaperone protein HSP90β. FASEB J. 2016;30:1712-23 pubmed 出版商
  147. Tang S, Chen H, Cheng Y, Nasir M, Kemper N, Bao E. The interactive association between heat shock factor 1 and heat shock proteins in primary myocardial cells subjected to heat stress. Int J Mol Med. 2016;37:56-62 pubmed 出版商
  148. Debruyne D, Bhatnagar N, Sharma B, Luther W, Moore N, Cheung N, et al. ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT. Oncogene. 2016;35:3681-91 pubmed 出版商
  149. Dimitrova N, Gocheva V, Bhutkar A, Resnick R, Jong R, Miller K, et al. Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development. Cancer Discov. 2016;6:188-201 pubmed 出版商
  150. Moriwaki K, Farias Luz N, Balaji S, De Rosa M, O Donnell C, Gough P, et al. The Mitochondrial Phosphatase PGAM5 Is Dispensable for Necroptosis but Promotes Inflammasome Activation in Macrophages. J Immunol. 2016;196:407-15 pubmed 出版商
  151. Robles Oteiza C, Taylor S, Yates T, Cicchini M, Lauderback B, Cashman C, et al. Recombinase-based conditional and reversible gene regulation via XTR alleles. Nat Commun. 2015;6:8783 pubmed 出版商
  152. Webber P, Park C, Qui M, Ramalingam S, Khuri F, Fu H, et al. Combination of heat shock protein 90 and focal adhesion kinase inhibitors synergistically inhibits the growth of non-small cell lung cancer cells. Oncoscience. 2015;2:765-776 pubmed
  153. Joshi A, Barabutis N, Birmpas C, Dimitropoulou C, Thangjam G, Cherian Shaw M, et al. Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function. Am J Physiol Lung Cell Mol Physiol. 2015;309:L1410-9 pubmed 出版商
  154. Hedstrom E, Pederiva C, Farnebo J, Nodin B, Jirstrom K, Brennan D, et al. Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome. Cell Death Dis. 2015;6:e1892 pubmed 出版商
  155. Yeung H, Lo P, Ng D, Fong W. Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model. Cell Mol Immunol. 2017;14:223-234 pubmed 出版商
  156. Ho D, Kim H, Kim J, Sim H, Ahn H, Kim J, et al. Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression. Mol Brain. 2015;8:54 pubmed 出版商
  157. Ashford A, Dunkley T, Cockerill M, Rowlinson R, Baak L, Gallo R, et al. Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome. Cell Mol Life Sci. 2016;73:883-900 pubmed 出版商
  158. Granato M, Gilardini Montani M, Filardi M, Faggioni A, Cirone M. Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression. Oncotarget. 2015;6:29543-54 pubmed 出版商
  159. Hussein M, Shrestha E, Ouimet M, Barrett T, Leone S, Moore K, et al. LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2. PLoS ONE. 2015;10:e0135218 pubmed 出版商
  160. Krawczyk K, Yao Mattisson I, Ekman M, Oskolkov N, Grantinge R, Kotowska D, et al. Myocardin Family Members Drive Formation of Caveolae. PLoS ONE. 2015;10:e0133931 pubmed 出版商
  161. Gurt I, Artsi H, Cohen Kfir E, Hamdani G, Ben Shalom G, Feinstein B, et al. The Sirt1 Activators SRT2183 and SRT3025 Inhibit RANKL-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages and Down-Regulate Sirt3 in Sirt1 Null Cells. PLoS ONE. 2015;10:e0134391 pubmed 出版商
  162. Chiou S, Winters I, Wang J, Naranjo S, Dudgeon C, Tamburini F, et al. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing. Genes Dev. 2015;29:1576-85 pubmed 出版商
  163. Ueda S, Kokaji Y, Simizu S, Honda K, Yoshino K, Kamisoyama H, et al. Chicken heat shock protein HSPB1 increases and interacts with αB-crystallin in aged skeletal muscle. Biosci Biotechnol Biochem. 2015;79:1867-75 pubmed 出版商
  164. Belian E, Noseda M, Abreu Paiva M, Leja T, Sampson R, Schneider M. Forward Programming of Cardiac Stem Cells by Homogeneous Transduction with MYOCD plus TBX5. PLoS ONE. 2015;10:e0125384 pubmed 出版商
  165. O Brien R, DeGiacomo F, Holcomb J, Bonner A, Ring K, Zhang N, et al. Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo. J Biol Chem. 2015;290:19287-306 pubmed 出版商
  166. Brito H, Martins A, Lavrado J, Mendes E, Francisco A, Santos S, et al. Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives. PLoS ONE. 2015;10:e0126891 pubmed 出版商
  167. Yeh J, Kreimer S, Walker S, Emori M, Krystal H, Richardson A, et al. Granulin, a novel STAT3-interacting protein, enhances STAT3 transcriptional function and correlates with poorer prognosis in breast cancer. Genes Cancer. 2015;6:153-68 pubmed
  168. Sato M, Matsubara T, Adachi J, Hashimoto Y, Fukamizu K, Kishida M, et al. Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model. PLoS ONE. 2015;10:e0126483 pubmed 出版商
  169. Cheng W, Ainiwaer A, Xiao L, Cao Q, Wu G, Yang Y, et al. Role of the novel HSP90 inhibitor AUY922 in hepatocellular carcinoma: Potential for therapy. Mol Med Rep. 2015;12:2451-6 pubmed 出版商
  170. Wang Y, Kuramitsu Y, Kitagawa T, Tokuda K, Baron B, Akada J, et al. The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX. Target Oncol. 2015;10:575-81 pubmed 出版商
  171. Min K, Liggett J, Silva G, Wu W, Wang R, Shen R, et al. NAG-1/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway. Oncogene. 2016;35:377-88 pubmed 出版商
  172. Vashist S, Ureña L, Gonzalez Hernandez M, Choi J, de Rougemont A, Rocha Pereira J, et al. Molecular chaperone Hsp90 is a therapeutic target for noroviruses. J Virol. 2015;89:6352-63 pubmed 出版商
  173. Lee A, Kranzusch P, Cate J. eIF3 targets cell-proliferation messenger RNAs for translational activation or repression. Nature. 2015;522:111-4 pubmed 出版商
  174. López Bernardo E, Anedda A, Sánchez Pérez P, Acosta Iborra B, Cadenas S. 4-Hydroxynonenal induces Nrf2-mediated UCP3 upregulation in mouse cardiomyocytes. Free Radic Biol Med. 2015;88:427-438 pubmed 出版商
  175. Clark P, Kim R, Pober J, Kluger M. Tumor necrosis factor disrupts claudin-5 endothelial tight junction barriers in two distinct NF-κB-dependent phases. PLoS ONE. 2015;10:e0120075 pubmed 出版商
  176. Shrestha S, Sun Y, Lufkin T, Kraus P, Or Y, Garcia Y, et al. Tetratricopeptide repeat domain 9A negatively regulates estrogen receptor alpha activity. Int J Biol Sci. 2015;11:434-47 pubmed 出版商
  177. Tristante E, Martínez C, Jiménez S, Mora L, Carballo F, Martínez Lacaci I, et al. Association of a characteristic membrane pattern of annexin A2 with high invasiveness and nodal status in colon adenocarcinoma. Transl Res. 2015;166:196-206 pubmed 出版商
  178. Hodgson A, Wier E, Fu K, Sun X, Yu H, Zheng W, et al. Metalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction. PLoS Pathog. 2015;11:e1004705 pubmed 出版商
  179. Wnorowski A, Sadowska M, Paul R, Singh N, Boguszewska Czubara A, Jimenez L, et al. Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells. Cell Signal. 2015;27:997-1007 pubmed 出版商
  180. Riebold M, Kozany C, Freiburger L, Sattler M, Buchfelder M, Hausch F, et al. A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease. Nat Med. 2015;21:276-80 pubmed 出版商
  181. Guo Y, Liu J, Elfenbein S, Ma Y, Zhong M, Qiu C, et al. Characterization of the mammalian miRNA turnover landscape. Nucleic Acids Res. 2015;43:2326-41 pubmed 出版商
  182. Zeng J, Ekman M, Grossi M, Svensson D, Nilsson B, Jiang C, et al. Vasopressin-induced mouse urethral contraction is modulated by caveolin-1. Eur J Pharmacol. 2015;750:59-65 pubmed 出版商
  183. Hirakawa H, Fujisawa H, Masaoka A, Noguchi M, Hirayama R, Takahashi M, et al. The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells. Cancer Med. 2015;4:426-36 pubmed 出版商
  184. Ohno M, Kanayama T, Moore R, Ray M, Negishi M. The roles of co-chaperone CCRP/DNAJC7 in Cyp2b10 gene activation and steatosis development in mouse livers. PLoS ONE. 2014;9:e115663 pubmed 出版商
  185. Maruyama A, Mimura J, Itoh K. Non-coding RNA derived from the region adjacent to the human HO-1 E2 enhancer selectively regulates HO-1 gene induction by modulating Pol II binding. Nucleic Acids Res. 2014;42:13599-614 pubmed 出版商
  186. Ohoka N, Nagai K, Hattori T, Okuhira K, Shibata N, Cho N, et al. Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway. Cell Death Dis. 2014;5:e1513 pubmed 出版商
  187. Cubeñas Potts C, Srikumar T, Lee C, Osula O, Subramonian D, Zhang X, et al. Identification of SUMO-2/3-modified proteins associated with mitotic chromosomes. Proteomics. 2015;15:763-72 pubmed 出版商
  188. Jung H, Tatar A, Tu Y, Nobumori C, Yang S, Goulbourne C, et al. An absence of nuclear lamins in keratinocytes leads to ichthyosis, defective epidermal barrier function, and intrusion of nuclear membranes and endoplasmic reticulum into the nuclear chromatin. Mol Cell Biol. 2014;34:4534-44 pubmed 出版商
  189. Gupta A, Keshri G, Yadav A, Gola S, Chauhan S, Salhan A, et al. Superpulsed (Ga-As, 904 nm) low-level laser therapy (LLLT) attenuates inflammatory response and enhances healing of burn wounds. J Biophotonics. 2015;8:489-501 pubmed 出版商
  190. Menon M, Sawada A, Chaturvedi A, Mishra P, Schuster Gossler K, Galla M, et al. Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis. PLoS Genet. 2014;10:e1004558 pubmed 出版商
  191. Park S, Park J, Kim Y, Song S, Kwon H, Lee Y. Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells. Cell Stress Chaperones. 2015;20:149-57 pubmed 出版商
  192. Ronzitti G, Bucci G, Emanuele M, Leo D, Sotnikova T, Mus L, et al. Exogenous ?-synuclein decreases raft partitioning of Cav2.2 channels inducing dopamine release. J Neurosci. 2014;34:10603-15 pubmed 出版商
  193. Zhang P, Wei Y, Wang L, Debeb B, Yuan Y, Zhang J, et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol. 2014;16:864-75 pubmed 出版商
  194. Rappa F, Sciume C, Lo Bello M, Bavisotto C, Marino Gammazza A, Barone R, et al. Comparative analysis of Hsp10 and Hsp90 expression in healthy mucosa and adenocarcinoma of the large bowel. Anticancer Res. 2014;34:4153-9 pubmed
  195. Lo Sasso G, Menzies K, Mottis A, Piersigilli A, Perino A, Yamamoto H, et al. SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis. PLoS ONE. 2014;9:e103573 pubmed 出版商
  196. Baraz R, Cisterne A, Saunders P, Hewson J, Thien M, Weiss J, et al. mTOR inhibition by everolimus in childhood acute lymphoblastic leukemia induces caspase-independent cell death. PLoS ONE. 2014;9:e102494 pubmed 出版商
  197. Lo Sasso G, Ryu D, Mouchiroud L, Fernando S, Anderson C, Katsyuba E, et al. Loss of Sirt1 function improves intestinal anti-bacterial defense and protects from colitis-induced colorectal cancer. PLoS ONE. 2014;9:e102495 pubmed 出版商
  198. Yamauchi T, Nishiyama M, Moroishi T, Yumimoto K, Nakayama K. MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24. Mol Cell Biol. 2014;34:3321-40 pubmed 出版商
  199. Tam A, Wadsworth S, Dorscheid D, Man S, Sin D. Estradiol increases mucus synthesis in bronchial epithelial cells. PLoS ONE. 2014;9:e100633 pubmed 出版商
  200. Ballana E, Badia R, Terradas G, Torres Torronteras J, Ruiz A, Pauls E, et al. SAMHD1 specifically affects the antiviral potency of thymidine analog HIV reverse transcriptase inhibitors. Antimicrob Agents Chemother. 2014;58:4804-13 pubmed 出版商
  201. Rogon C, Ulbricht A, Hesse M, Alberti S, Vijayaraj P, Best D, et al. HSP70-binding protein HSPBP1 regulates chaperone expression at a posttranslational level and is essential for spermatogenesis. Mol Biol Cell. 2014;25:2260-71 pubmed 出版商
  202. Zahreddine H, Culjkovic Kraljacic B, Assouline S, Gendron P, Romeo A, Morris S, et al. The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation. Nature. 2014;511:90-3 pubmed 出版商
  203. Kitagawa K, Shibata K, Matsumoto A, Matsumoto M, Ohhata T, Nakayama K, et al. Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development. Mol Cell Biol. 2014;34:2732-44 pubmed
  204. Moroishi T, Yamauchi T, Nishiyama M, Nakayama K. HERC2 targets the iron regulator FBXL5 for degradation and modulates iron metabolism. J Biol Chem. 2014;289:16430-41 pubmed 出版商
  205. Sun Y, Chung H, Woo A, Lin V. Protein arginine methyltransferase 6 enhances ligand-dependent and -independent activity of estrogen receptor ? via distinct mechanisms. Biochim Biophys Acta. 2014;1843:2067-78 pubmed 出版商
  206. Havel J, Li Z, Cheng D, Peng J, Fu H. Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway. Oncogene. 2015;34:1487-98 pubmed 出版商
  207. Walker S, Liu S, Xiang M, Nicolais M, Hatzi K, Giannopoulou E, et al. The transcriptional modulator BCL6 as a molecular target for breast cancer therapy. Oncogene. 2015;34:1073-82 pubmed 出版商
  208. Swärd K, Albinsson S, Rippe C. Arterial dysfunction but maintained systemic blood pressure in cavin-1-deficient mice. PLoS ONE. 2014;9:e92428 pubmed 出版商
  209. Ekman M, Uvelius B, Albinsson S, Swärd K. HIF-mediated metabolic switching in bladder outlet obstruction mitigates the relaxing effect of mitochondrial inhibition. Lab Invest. 2014;94:557-68 pubmed 出版商
  210. Chen D, Sun Y, Yuan Y, Han Z, Zhang P, Zhang J, et al. miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion. PLoS Genet. 2014;10:e1004177 pubmed 出版商
  211. Piao H, Yuan Y, Wang M, Sun Y, Liang H, Ma L. ?-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-?B signalling. Nat Cell Biol. 2014;16:245-54 pubmed 出版商
  212. Fan X, Jin W, Lu J, Wang J, Wang Y. Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation. Nat Neurosci. 2014;17:471-80 pubmed 出版商
  213. Liu S, Walker S, Nelson E, Cerulli R, Xiang M, Toniolo P, et al. Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2. Mol Cancer Ther. 2014;13:1194-205 pubmed 出版商
  214. Marshall K, Edwards M, Krenz M, Davis J, Baines C. Proteomic mapping of proteins released during necrosis and apoptosis from cultured neonatal cardiac myocytes. Am J Physiol Cell Physiol. 2014;306:C639-47 pubmed 出版商
  215. Lee J, Kim W, Gygi S, Ye Y. Characterization of the deubiquitinating activity of USP19 and its role in endoplasmic reticulum-associated degradation. J Biol Chem. 2014;289:3510-7 pubmed 出版商
  216. Swärd K, Sadegh M, Mori M, Erjefalt J, Rippe C. Elevated pulmonary arterial pressure and altered expression of Ddah1 and Arg1 in mice lacking cavin-1/PTRF. Physiol Rep. 2013;1:e00008 pubmed 出版商
  217. Jockusch H, Holland A, Staunton L, Schmitt John T, Heimann P, Dowling P, et al. Pathoproteomics of testicular tissue deficient in the GARP component VPS54: the wobbler mouse model of globozoospermia. Proteomics. 2014;14:839-52 pubmed 出版商
  218. Trinh A, Kim S, Chang H, Mastrocola A, Tibbetts R. Cyclin-dependent kinase 1-dependent phosphorylation of cAMP response element-binding protein decreases chromatin occupancy. J Biol Chem. 2013;288:23765-75 pubmed 出版商
  219. Jung H, Nobumori C, Goulbourne C, Tu Y, Lee J, Tatar A, et al. Farnesylation of lamin B1 is important for retention of nuclear chromatin during neuronal migration. Proc Natl Acad Sci U S A. 2013;110:E1923-32 pubmed 出版商
  220. Ipenberg I, Guttmann Raviv N, Khoury H, Kupershmit I, Ayoub N. Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase. J Biol Chem. 2013;288:14681-7 pubmed 出版商
  221. Danielson L, Park D, Rotllan N, Chamorro Jorganes A, Guijarro M, Fernandez Hernando C, et al. Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J. 2013;27:1460-7 pubmed 出版商
  222. Krzysik Walker S, González Mariscal I, Scheibye Knudsen M, Indig F, Bernier M. The biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERR?. Mol Pharmacol. 2013;83:157-66 pubmed 出版商
  223. Diril M, Ratnacaram C, Padmakumar V, Du T, Wasser M, Coppola V, et al. Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. Proc Natl Acad Sci U S A. 2012;109:3826-31 pubmed 出版商
  224. Wan F, Weaver A, Gao X, Bern M, Hardwidge P, Lenardo M. IKK? phosphorylation regulates RPS3 nuclear translocation and NF-?B function during infection with Escherichia coli strain O157:H7. Nat Immunol. 2011;12:335-43 pubmed 出版商